How to overcome ‘double-counting’ in cost-utility analyses Newsletter Article 09 February 2013 Pages: 2 - 2
APA recommends donepezil as first-line agent for Alzheimer’s Newsletter Article 09 February 2013 Pages: 2 - 2
Pros and cons of critical-care pathways in managing stroke Robert Carlson Newsletter Article 09 February 2013 Pages: 3 - 4
Direct medical charges for arthritis are substantial Newsletter Article 09 February 2013 Pages: 6 - 6
Society ‘should prefer’ primary angioplasty to alteplase post-MI Newsletter Article 09 February 2013 Pages: 7 - 7
ASHP survey reveals improvements in pharmacy practice Newsletter Article 09 February 2013 Pages: 8 - 8
Mercaptamine ↑ life expectancy, ↓ costs in infantile cystinosis Newsletter Article 09 February 2013 Pages: 8 - 8
Study refutes myth that old age means higher healthcare costs Newsletter Article 09 February 2013 Pages: 8 - 8
Angioplasty of benefit but doesn’t increase costs in low-risk MI? Newsletter Article 09 February 2013 Pages: 9 - 9
Consider health outcomes data when making purchasing decisions Newsletter Article 09 February 2013 Pages: 10 - 10
Captopril leads to substantial cost savings in diabetic nephropathy Newsletter Article 09 February 2013 Pages: 10 - 10
US MCO-designed programme aims to improve asthma care Newsletter Article 09 February 2013 Pages: 11 - 12